Hormonal regulation of tumor necrosis factor-α, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus?

Annals of the New York Academy of Sciences

Volumn 876, Issue , 1999, Pages 14-31

  Wilder, Ronald L ^a,b   Elenkov, Ilia J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ESTROGEN; INTERLEUKIN 10; INTERLEUKIN 12; ORAL CONTRACEPTIVE AGENT; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; DISEASE ACTIVITY; ESTROGEN THERAPY; HORMONAL REGULATION; HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; MACROPHAGE; MENOPAUSE; PREGNANCY; PUERPERIUM; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032814986     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07619.x     Document Type: Conference Paper

References (152)

1. 1. FELDMANN, M., F. M. BRENNAN & R. N. MAINI. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.
2. 2. KOTAKE, S., H. R. SCHUMACHER, JR., C. H. YARBORO, T. K. ARAYSSI, J. A. PANDO, K. S. KANIK, M. F. GOURLEY, J. H. KLIPPEL & R. L. WILDER. 1997. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc. Assoc. Am. Physicians 109(3): 286-301.
3. 3. MITAMURA, K., H. KANG, Y. TOMITA, H. HASHIMOTO, S. SAWADA & T. HORIE. 1991. Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 85(3): 386-391.
4. 4. SWAAK, A. J., H. G. VAN DEN BRINK & L. A. AARDEN. 1996. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand. J. Rheumatol. 25(4): 233-238.
5. 5. KROEMER, G., F. HIRSCH, A. GONZALEZ-GARCIA & C. MARTINEZ. 1996. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 24(1): 25-33.
6. 6. HORWITZ, D. A., J. D. GRAY, S. C. BEHRENDSEN, M. KUBIN, M. RENGARAJU, K. OHTSUKA & G. TRINCHIERI. 1998. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum. 41(5): 838-844.
7. 7. DEL PRETE, G. 1998. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol. 16(3-4): 427-455.
8. 8. WILDER, R. L. 1995. Neuroendocrine-immune interactions and autoimmunity. Annu. Rev. Immunol. 13: 307-338.
9. 9. DA SILVA, J. A. 1995. Sex hormones, glucocorticoids and autoimmunity: Facts and hypotheses. Ann. Rheum. Dis. 54(1): 6-16.
10. 10. WILDER, R. L. 1996. Hormones and autoimmunity: Animal models of arthritis. Baillieres Clin. Rheumatol. 10: 259-271.
11. 11. WILDER, R. L. 1996. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J. Rheum. 44 (Suppl.): 10-12.
12. 12. ELENKOV, I. J., J. HOFFMAN & R. L. WILDER. 1997. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol. Med. Today 3(9): 379-383.
13. 13. WILDER, R. L. 1998. Hormones, pregnancy, and autoimmune diseases. Ann. N. Y. Acad. Sci. 840: 45-50.
14. 14. CUTOLO, M. & A. T. MASI. 1998. Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypotheses. J. Rheumatol. 25: 1041-1047.
15. 15. ELENKOV, I. J., D. A. PAPANICOLAOU, R. L. WILDER & G. P. CHROUSOS. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc. Assoc. Am. Physicians 108(5): 374-381.
16. 16. WAAGE, A. & O. BAKKE. 1988. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63(2): 299-302.
17. 17. PETROVSKY, N. & L. C. HARRISON. 1998. The chronobiology of human cytokine production. Int. Rev. Immunol. 16(5-6): 635-649.
18. 18. ELENKOV, I. J., G. HASKO, K. J. KOVACS & E. S. VIZI. 1995. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J. Neuroimmunol. 61(2): 123-131.
19. 19. PANINA-BORDIGNON, P., D. MAZZEO, P. D. LUCIA, D. D'AMBROSIO, R. LANG, L. FABBRI, C. SELF & F. SINIGAGLIA. 1997. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100: 1513-1519.
20. 20. GUIRAO, X., A. KUMAR, J. KATZ, M. SMITH, E. LIN, C. KEOGH, S. E. CALVANO & S. F. LOWRY. 1997. Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am. J. Physiol. 273: E1203-1208.
21. 21. CHENG, J. B., J. W. WATSON, C. J. PAZOLES, J. D. ESKRA, R. J. GRIFFITHS, V. L. COHAN, C. R. TURNER, H. J. SHOWELL & E. R. PETTIPHER. 1997. The phosphodiesterase type 4 (PDE4) inhibitor CP-80, 633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: Effect of adrenalectomy. J. Pharmacol. Exp. Ther. 280(2): 621-626.
22. 22. WOICIECHOWSKY, C., K. ASADULLAH, D. NESTLER, B. EBERHARDT, C. PLATZER, B. SCHONING, F. GLOCKNER, W. R. LANKSCH, H. D. VOLK & W. D. DOCKE. 1998. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4(7): 808-813.
23. 23. KAVELAARS, A., M. VAN DE POL, J. ZULSTRA & C. J. HEIJNEN. 1997. Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J. Neuroimmunol. 77(2): 214-216.
24. 24. DESHPANDE, R., H. KHALILI, R. G. PERGOLIZZI, S. D. MICHAEL & M. D. CHANG. 1997. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am. J. Reprod. Immunol. 38(1): 46-54.
25. 25. CHAO, T. C., P. J. VAN ALTEN, J. A. GREAGER & R. J. WALTER. 1995. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol. 160(1): 43-49.
26. 26. COHEN-SOLAL, M. E., A. M. GRAULET, M. A. DENNE, J. GUERIS, D. BAYLINK & M. C. DE VERNEJOUL. 1993. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines. J. Clin. Endocrinol. Metab. 77(6): 1648-1653.
27. 27. PACIFICI, R., C. BROWN, E. PUSCHECK, E. FRIEDRICH, E. SLATOPOLSKY, D. MAGGIO, R. MCCRACKEN & L. V. AVIOLI. 1991. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA 88(12): 5134-5138.
28. 28. EVANS, M. J., S. MACLAUGHLIN, R. D. MARGIN & N. I. ABDOU. 1997. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin. Immunol. Immunopathol. 82(3): 258-262.
29. 29. MILLER, L. & J. S. HUNT. 1998. Regulation of TNF-alpha production in activated mouse macrophages by progesterone. J. Immunol. 160: 5098-5104.
30. 30. CHROUSOS, G. P. & P. W. GOLD. 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis [published erratum in JAMA 1992 268(2): 200]. JAMA 267(9): 1244-1252.
31. 31. CHROUSOS, G. P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation [see comments]. N. Engl. J. Med. 332(20): 1351-1362.
32. 32. SEGAL, B. M., B. K. DWYER & E. M. SHEVACH. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187: 537-546.
33. 33. TORPY, D. J. & G. P. CHROUSOS. 1996. The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system. Baillieres Clin. Rheumatol. 10(2): 181-198.
34. 34. CHROUSOS, G. P., D. J. TORPY & P. W. GOLD. 1998. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann. Intern. Med. 129: 229-240.
35. 35. KIRSCHBAUM, C., N. SCHOMMER, I. FEDERENKO, J. GAAB, O. NEUMANN, M. OELLERS, N. ROHLEDER, A. UNTIEDT, J. HANKER, K. M. PIRKE & D. H. HELLHAMMER. 1996. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men [see comments]. J Clin. Endocrinol. Metab. 81(10): 3639-3643.
36. 36. VAMVAKOPOULOS, N. C. & G. P. CHROUSOS. 1993. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92(4): 1896-1902.
37. 37. HAAS, D. A. & S. R. GEORGE. 1989. Estradiol or ovariectomy decreases CRF synthesis in hypothalamus. Brain Res. Bull. 23(3): 215-218.
38. 38. BOHLER, H. C., JR., R. T. ZOELLER, J. C. KING, B. S. RUBIN, R. WEBER & G. R. MERRIAM. 1990. Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat. Brain Res. Mol. Brain Res. 8(3): 259-262.
39. 39. GALLUCCI, W. T., A. BAUM, L. LAUE, D. S. RABIN, G. P. CHROUSOS, P. W. GOLD & M. A. KLING. 1993. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. Health Psychol. 12(5): 420-425.
40. 40. LINDHOLM, J. & N. SCHULTZ-MOLLER. 1973. Plasma and urinary cortisol in pregnancy and during estrogen-gestagen treatment. Scand. J. Clin. Lab. Invest. 31(1): 119-122.
41. 41. PEIFFER, A., B. LAPOINTE & N. BARDEN. 1991. Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain. Endocrinology 129(4): 2166-2174.
42. 42. GREENSTEIN, B. D., E. F. DE BRIDGES & F. T. FITZPATRICK. 1992. Aromatase inhibitors regenerate the thymus in aging male rats. Int. J. Immunopharmacol. 14(4): 541-553.
43. 43. MASI, A. T. 1994. Incidence of rheumatoid arthritis: Do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis? [editorial]. Br. J. Rheumatol. 33(8): 697-699.
44. 44. WEYAND, C. M., D. SCHMIDT, U. WAGNER & J. J. GORONZY. 1998. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 41: 817-822.
45. 45. SUZUKI, M., M. TAKAHASHI, S. MIYAMOTO, H. HOSHINO, K. KUSHIDA, M. MIURA & T. INOUE. 1998. The effects of menopausal status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. Br. J. Rheumatol. 37(6): 653-658.
46. 46. RANNEVIK, G., S. JEPPSSON, O. JOHNELL, B. BIERRE, Y. LAURELL-BORULF & L. SVANBERG. 1995. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones. SHBG and bone mineral density. Maturitas 21(2): 103-113.
47. 47. SAMBROOK, P. N., J. A. EISMAN, G. D. CHAMPION & N. A. POCOCK. 1988. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 31(8): 973-978.
48. 48. SAMBROOK, P., J. BIRMINGHAM, D. CHAMPION, P. KELLY, S. KEMPLER, J. FREUND & J. EISMAN, 1992. Postmenopausal bone loss in rheumatoid arthritis: Effect of estrogens and androgens. J. Rheumatol. 19(3): 357-361.
49. 49. BELLIDO, T., R. L. JILKA, B. F. BOYCE, G. GIRASOLE, H. BROXMEYER, S. A. DALRYMPLE, R. MURRAY & S. C. MANOLAGAS. 1995. Regulation of interleukin-6, osteoelastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95(6): 2886-2895.
50. 50. CUTOLO, M., A. SULLI, B. SERIOLO, S. ACCARDO & A. T. MASI. 1995. Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 13(2): 217-226.
51. 51. PAPANICOLAOU, D. A., R. L. WILDER, S. C. MANOLAGAS & G. P. CHROUSOS. 1998. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128(2): 127-137.
52. 52. KOLAKE, S., K. SATO, K. J. KIM, N. TAKAHASHI, N. UDAGAWA, I. NAKAMURA, A. YAMAGUCHI, T. KISHIMOTO, T. SUDA & S. KASHIWAZAKI. 1996. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J. Bone Miner. Res. 11: 88-95.
53. 53. LAHITA, R. G., R. BUCALA, H. L. BRADLOW & J. FISHMAN. 1985. Determination of 16 alpha-hydroxyestrone by radioimmunoassay in systemic lupus erythematosus. Arthritis Rheum. 28(10): 1122-1127.
54. 54. LAHITA, R. G. 1992. The effects of sex hormones on the immune system in pregnancy. Am. J. Reprod. Immunol. 28(3-4): 136-137.
55. 55. LAHITA, R. G. 1992. Sex steroids and SLE: Metabolism of androgens to estrogens [editorial]. Lupus 1(3): 125-127.
56. 56. LAHITA, R. G., C. Y. CHENG, C. MONDER & C. W. BARDIN. 1992. Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: Worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J. Rheumatol. 19(4): 547-555.
57. 57. LAHITA, R. G. 1992. The importance of estrogens in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 63(1): 17-18.
58. 58. LAHITA, R. G. 1996. The basis for gender effects in the connective tissue diseases. Ann. Med. Interne 147(4): 241-247.
59. 59. WILDER, R. L. 1990. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J. Rheumatol. Suppl. 44: 10-12.
60. 60. HAZES, J. M. B. A. DUKMANS, J. P. VANDENBROUCKE, R. R. DE VRIES & A. CATS. 1990. Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum. 33(12): 1770-1775.
61. 61. HAZES, J. M. 1991. Pregnancy and its effect on the risk of developing rheumatoid arthritis. Ann. Rheum. Dis. 50: 71-74.
62. 62. SPECTOR, T. D. & J. A. DA SILVA. 1992. Pregnancy and rheumatoid arthritis: An overview. Am. J. Reprod. Immunol. 28(3-4): 222-225.
63. 63. NELSON, J. L., K. A. HUGHES, A. G. SMITH, B. B. NISPEROS, A. M. BRANCHAUD & J. A. HANSEN, 1993. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis [see comments]. N. Engl. J. Med. 329(7): 466-471.
64. 64. NELSON, J. L. 1998. Pregnancy immunology and autoimmune disease. J. Reprod. Med. 43: 335-340.
65. 65. MASI, A. T., S. L. FEIGENBAUM & R. T. CHATTERTON. 1995. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems. Semin. Arthritis Rheum. 25: 1-27.
66. 66. SILMAN, A., A. KAY & P. BRENNAN. 1992. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum. 35: 152-155.
67. 67. SPECTOR, T. D., E. ROMAN & A. J. SILMAN. 1990. The pill, parity, and rheumatoid arthritis. Arthritis Rheum. 33(6): 782-789.
68. 68. SILMAN, A. J. 1992. Parity status and the development of rheumatoid arthritis. Am. J. Reprod. Immunol. 28(3-4): 228-230.
69. 69. SILMAN, A. J. 1994. Epidemiology of rheumatoid arthritis. Apmis 102(10): 721-728.
70. 70. BRENNAN, P. & A. SILMAN. 1994. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum. 37(6): 808-813.
71. 71. MAGIAKOU, M. A., G. MASTORAKOS, D. RABIN, A. N. MARGIORIS, B. DUBBERT, A. E. CALOGERO, C. TSIGOS, P. J. MUNSON & G. P. CHROUSOS. 1996. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin. Endocrinol. 44(4): 419-428.
72. 72. MAGIAKOU, M. A., G. MASTORAKOS, D. RABIN, B. DUBBERT, P. W. GOLD & G. P. CHROUSOS. 1996. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period; Implications for the increase in psychiatric manifestations at this time. J. Clin. Endocrinol. Metab. 81(5): 1912-1917.
73. 73. AMICO, J. A. & B. E. FINLEY. 1986. Breast stimulation in cycling women, pregnant women and a woman with induced lactation: Pattern of release of oxytocin, prolactin and luteinizing hormone. Clin. Endocrinol. 25(2): 97-106.
74. 74. AMICO, J. A., J. M. JOHNSTON & A. H. VAGNUCCI. 1994. Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women. Endocr. Res. 20(1): 79-87.
75. 75. PRITCHARD, M. H. 1992. An examination of the role of female hormones and pregnancy as risk factors for rheumatoid arthritis, using a male population as control group. Br. J. Rheumatol. 31(6): 395-399.
76. 76. FORMBY, B. 1995. Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol. Metab. Clin. North Am. 24(1): 187-205.
77. 77. MARZI, M., A. VIGANO, D. TRABATTONI, M. L. VILLA, A. SALVAGGIO, E. CLERICI & M. CLERICI. 1996. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106(1): 127-133.
78. 78. REINHARD, G., A. NOLL, H. SCHLEBUSCH, P. MALLMANN & A. V. RUECKER. 1998. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem. Biophys. Res. Commun. 245(3): 933-938.
79. 79. SMITH, J. B. & J. G. FORT. 1996. Treatment of rheumatoid arthritis by immunization with mononuclear white blood cells: Results of a preliminary trial. J. Rheumatol. 23(2): 220-225.
80. 80. RALSTON, S. H., R. G. RUSSELL & M. GOWEN. 1990. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclcar cells in postmenopausal women. J. Bone Miner. Res. 5(9): 983-988.
81. 81. DELASSUS, S., G. C. COUTINHO, C. SAUCIER, S. DARCHE & P. KOURILSKY. 1994. Differential cytokine expression in maternal blood and placenta during murine gestation. J. Immunol. 152(5): 2411-2420.
82. 82. SZEKERES-BARTHO, J., Z. FAUST, P. VARGA, L. SZEREDAY & K. KELEMEN. 1996. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am. J. Reprod. Immunol. 35: 348-351.
83. 83. LEA, R. G., S. MCINTYRE, J. D. BAIRD & D. A. CLARK. 1998. Tumor necrosis factor-alpha mRNA-positive cells in spontaneous resorption in rodents. Am. J. Reprod. Immunol. 39: 50-57.
84. 84. CHAOUAT, G., E. MENU, D. A. CLARK, M. DY, M. MINKOWSKI & T. G. WEGMANN. 1990. Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J. Reprod. Fertil. 89(2): 447-458.
85. 85. SACKS, G. P., D. SCOTT, H. TIVNANN, T. MIRE-SLUIS, I. L. SARGENT & C. W. REDMAN. 1997. Interleukin-12 and pre-eclampsia. J. Reprod. Immunol. 34: 155-158.
86. 86. DUDLEY, D. J. 1997. Is pre-eclampsia a Th-1-type immune condition? J. Reprod. Immunol. 34: 159-161.
87. 87. CLARK, D. A., G. CHAOUAT, P. C. ARCK, H. W. MITTRUECKER & G. A. LEVY. 1998. Cutting edge: Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fg12 prothombinase. J. Immunol. 160: 545-549.
88. 88. LIN, H., T. R. MOSMANN, L. GUILBERT, S. TUNTIPOPIPAT & T. G. WEGMANN. 1993. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151(9): 4562-4573.
89. 89. SZEREDAY, L., P. VARGA & J. SZEKERES-BARTHO. 1997. Cytokine production by lymphocytes in pregnancy. Am. J. Reprod. Immunol. 38(6): 418-422.
90. 90. RIVERA, D. L., S. M. OLISTER, X. LIU, J. H. THOMPSON, X. J. ZHANG, K. PENNLINE, R. AZUERO, D. A. CLARK & M. J. MILLER. 1998. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J. 12: 189-197.
91. 91. MATTHIESEN, L., C. EKERFELT, G. BERG & J. ERNERUDH. 1998. Increased numbers of circulating interferon-gamma and interleukin-4 - secreting cells during normal pregnancy. Am. J. Reprod. Immunol. 39(6): 362-367.
92. 92. LIM, K. J., O. A. ODUKOYA, R. A. AJJAN, T. C. LI, A. P. WEETMAN & I. D. COOKE. 1998. Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol. Hum. Reprod. 4(1): 77-81.
93. 93. HILL, J. A. 1992. Cytokines considered critical in pregnancy. Am. J. Reprod. Immunol. 28(3-4): 123-126.
94. 94. GAFTER, U., H. SREDNI, J. SEGAL & Y. KALECHMAN. 1997. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J. Clin. Immunol. 17: 408-419.
95. 95. PICCINNI, M. P., M. G. GIUDIZI, R. BIAGIOTTI, L. BELONI, L. GIANNARINI, S. SAMPOGNARO, P. PARRONCHI, R. MANETTI, F. ANNUNZIATO, C. LIVI, et al. 1995. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155(1): 128-133.
96. 96. PICCINNI, M. P. & S. ROMAGNANI. 1996. Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines. Immunol. Res. 15(2): 141-150.
97. 97. RAMIERZ, F., D. J. FOWELL, M. PUKLAVEC, S. SIMMONDS & D. MASON. 1996. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156(7): 2406-2412.
98. 98. PETROVSKY, N., P. MCNAIR & L. C. HARRISON. 1998. Diurnal rhythms of pro-inflammatory cytokines: Regulation by plasma cortisol and therapeutic implications. Cytokine 10: 307-312.
99. 99. SZEKERES-BARTHO, J., G. PAR, L. SZEREDAY, C. Y. SMART & I. ACHATZ. 1997. Progesterone and non-specific immunologic mechanisms in pregnancy. Am. J. Reprod. Immunol. 38(3): 176-182.
100. 100. STERNBERG, E. M., J. M. HILL, G. P. CHROUSOS, T. KAMILARIS, S. J. LISTWAK, P. W. GOLD & R. L. WILDER. 1989. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 86(7): 2374-2378.
101. 101. VISSER, J., D. METHORST, T. BRUNT, E. R. DE KLOET & L. NAGELKERKEN. 1998. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91: 4255-4264.
102. 102. LOCKSHIN, M. D. 1993. Does lupus flare during pregnancy? [editorial]. Lupus 2(1): 1-2.
103. 103. DERKSEN, R. H., H. W. BRUINSE, P. G. DE GROOT & L. KATER. 1994. Pregnancy in systemic lupus erythematosus: A prospective study. Lupus 3(3): 149-155.
104. 104. PETRI, M., D. HOWARD & J. REPKE. 1991. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience [see comments]. Arthritis Rheum. 34(12): 1538-1545.
105. 105. UROWITZ, M. B., D. D. GI ADMAN, V. T. FAREWELL, J. STEWART & J. MCDONALD. 1993. Lupus and pregnancy studies. Arthritis Rheum. 36(10): 1392-1397.
106. 106. LIMA, F., N. M. BUCHANAN, M. A. KHAMASHTA, S. KERSLAKE & G. R. HUGHES. 1995. Obstetric outcome in systemic lupus erythematosus. Semin. Arthritis Rheum. 25(3): 184-192.
107. 107. RUIZ-IRASTORZA, G., F. LIMA, J. AIVES, M. A. KHAMASHTA, J. SIMPSON, G. R. HUGHES & N. M. BUCHANAN. 1996. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br. J. Rheumatol. 35(2): 133-138.
108. 108. KHAMASHTA, M. A., G. RUIZ-IRASTORZA & G. R. HUGHES. 1997. Systemic lupus erythematosus flares during pregnancy. Rheum. Dis. Clin. North Am. 23(1): 15-30.
109. 109. LE HUONG, D., B. WECHSLER, D. VAUTHIER-BROUZES, J. SEEBACHER, G. LEFEBVRE, O. BLETRY, Y. DARBOIS, P. GODEAU & J. C. PIETTE. 1997. Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies. Br. J. Rheumatol. 36(7): 772-777.
110. 110. BUYON, J. P. 1998. The effects of pregnancy on autoimmune disease. J. Leukocyte Biol. 63(3): 281-287.
111. 111. PETRI, M. 1997. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North Am. 23: 1-13.
112. 112. JAMES, W. H. 1993. Rheumatoid arthritis, the contraceptive pill, and androgens. Ann. Rheum. Dis. 52: 470-474.
113. 113. MASI, A. T. 1995. Sex hormones and rheumatoid arthritis: Cause or effect relationships in a complex pathophysiology? Clin. Exp. Rheumatol. 13(2): 227-240.
114. 114. BRENNAN, P., C. BANKHEAD, A. SILMAN & D. SYMMONS. 1997. Oral contraceptives and rheumatoid arthritis: Results from a primary care-based incident case-control study. Semin. Arthritis Rheum. 26(6): 817-823.
115. 115. VAN DEN BRINK, H. R., W. F. LEMS, A. A. VAN EVERDINGEN & J. W. BIJLSMA. 1993. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann. Rheum. Dis. 52(4): 302-305.
116. 116. MACDONALD, A. G., E. A. MURPHY, H. A. CAPELL., U. Z. BANKOWSKA & S. H. RALSTON, 1994. Effects of hormone replacement therapy in rheumatoid arthritis: A double blind placebo-controlled study. Ann. Rheum. Dis. 53(1): 54-57.
117. 117. HALL, G. M., M. DANIELS, D. V. DOYLE & T. D. SPECTOR. 1994. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum. 37(10): 1499-1505.
118. 118. HALL, G. M., M. DANIELS, E. C. HUSKISSON & T. D. SPECTOR. 1994. A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann. Rheum. Dis. 53(2): 112-116.
119. 119. HALL, G. M., T. D. SPECTOR & P. D. DELMAS. 1995. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum. 38(7): 902-906.
120. 120. VAN VOLLENHOVEN, R. F. & J. L. MCGUIRE. 1994. Estrogen, progesterone, and testosterone: Can they be used to treat autoimmune diseases? Clevel. Clin. J. Med. 61(4): 276-284.
121. 121. SANCHEZ-GUERRERO, J., M. H. LIANG, E. W. KARLSON, D. J. HUNTER & G. A. COLDITZ. 1995. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus [see comments]. Ann. Intern. Med. 122(6): 430-433.
122. 122. LIANG, M. H. & E. W. KARLSON. 1996. Female hormone therapy and the risk of developing or exacerbating systemic lupus erythematosus or rheumatoid arthritis. Proc. Assoc. Am. Physicians. 108(1): 25-28.
123. 123. BUYON, J. P. 1996. Oral contraceptives in women with systemic lupus erythematosus. Ann. Med. Interne 147(4): 259-264.
124. 124. MEIER, C. R., M. C. STURKENBOOM, A. S. COIIEN & H. JICK. 1998. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J. Rheumatol. 25(8): 1515-1519.
125. 125. HUONG, D. L., B. WECHSLER, J. C. PIETTE, S. ARFI, C. GALLINARI, Y. DARBOIS, C. FRANCES & P. GODEAU. 1996. Risks of ovulation-induction therapy in systemic lupus erythematosus. Br. J. Rheumatol. 35(11): 1184-1186.
126. 126. CHIKANZA, I. C., P. PETROU, G. KINGSLEY, G. CHROUSOS & G. S. PANAYI. 1992. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis [see comments]. Arthritis Rheum. 35(11): 1281-1288.
127. 127. CROFFORD, L. J., K. T. KALOGERAS, G. MASTORAKOS, M. A. MAGIAKOU, J. WELLS, K. S. KANIK, P. W. GOLD, G. P. CHROUSOS & R. L. WILDER. 1997. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82(4): 1279-1283.
128. 128. CROFFORD, L. J., H. SANO, K. KARALIS, T. C. FRIEDMAN, H. R. EPPS, E. F. REMMERS, P. MATHERN, G. P. CHROUSOS & R. L. WILDER. 1993. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151(3): 1587-1596.
129. 129. CROFFORD, L. J., H. SANO, K. KARALIS, E. L. WEBSTER, E. A. GOLDMUNTZ, G. P. CHROUSOS & R. L. WILDER. 1992. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest. 90(6): 2555-2564.
130. 130. CROFFORD, L. J., H. SANO, K. KARALIS, E. A. WEBSTER, T. C. FRIEDMAN, G. P. CHROUSOS & R. L. WILDER. 1995. Local expression of corticotropin-releasing hormone in inflammatory arthritis. Ann. N. Y. Acad. Sci. 771: 459-471.
131. 131. BAERWALD, C. G., G. S. PANAYI & J. S. LANCHBURY. 1997. Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis. J. Rheumatol. 24(1): 215-216.
132. 132. HARKNESS, J. A., M. B. RICHTER, G. S. PANAYI, K. VAN DE PETTE, A. UNGER, R. POWNALL & M. GEDDAWI. 1982. Circadian variation in disease activity in rheumatoid arthritis. Br. Med. J. 284(6315): 551-554.
133. 133. HEROLD, M. & R. GUNTHER. 1987. Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis. Prog. Clin. Biol. Res. 227B: 271-279.
134. 134. NEECK, G., K. FEDERLIN, V. GRAEF, D. RUSCH & K. L. SCHMIDT. 1990. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Rheumatol. 17(1): 24-29.
135. 135. BELLAMY, N., R. B. SOTHERN, J. CAMPBELL & W. W. BUCHANAN. 1991. Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: Relation between discomfort and disability. Ann. Rheum. Dis. 50(4): 243-248.
136. 136. OLSEN, N. J., R. H. BROOKS & D. FURST. 1993. Variability of immunologic and clinical features in patients with rheumatoid arthritis studied over 24 hours. J. Rheumatol. 20(6): 940-943.
137. 137. MASERA, R. G., R. CARIGNOLA, A. H. STAURENGHI, M. L. SAKTORI, A. LAZZERO, G. GRIOT & A. ANGELI. 1994. Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases. Chronobiologia 21(1-2): 127-132.
138. 138. ARVIDSON, N. G., B. GUDBJORNSSON, L. ELFMAN, A. C. RYDEN, T. H. TOTTERMAN & R. HALLGREN. 1994. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann. Rheum. Dis. 53(8): 521-524.
139. 139. KIRWAN, J. R. 1995. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group [see comments]. N. Engl. J. Med. 333(3): 142-146.
140. 140. YAKUSHIJI, F., M. KITA, N. HIROI, H. UESHIBA, I. MONMA & Y. MIYACHI. 1995. Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing's syndrome. Endocr. J. 42(2): 219-223.
141. 141. POTTER, P. T. & A. J. ZAUTRA. 1997. Stressful life events' effects on rheumatoid arthritis disease activity. J. Consult. Clin. Psychol. 65(2): 319-323.
142. 142. ZAUTRA, A. J., J. HOFFMAN, P. POTTER, K. S. MATT, D. YOCUM & L. CASTRO. 1997. Examination of changes in interpersonal stress as a factor in disease exacerbations among women with rheumatoid arthritis. Ann. Behav. Med. 19(3): 279-286.
143. 143. ZAUTRA, A. J., M. H. BURLESON, K. S. MATT, S. ROTH & L. BURROWS. 1994. Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol. 13(2): 139-148.
144. 144. LATMAN, N. S. 1983. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am. J. Med. 74(6): 957-960.
145. 145. RUDGE, S. R., I. C. KOWANKO & P. L. DRURY. 1983. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. Ann. Rheum. Dis. 42(4): 425-430.
146. 146. KANIK, K. S., G. P. CHROUSOS, C. H. YARBORO, H. R. SCHUMACHER & R. L. WILDER. 1995. Pituitary-adrenal hormonal abnormalities in patients with new-onset synovitis. Arthritis Rheum. 38(Suppl.): 1453.
147. 147. HALL, J., E. F. MORAND, S. MEDBAK, M. ZAMAN, L. PERRY, N. J. GOULDING, P. J. MADDISON & J. P. O'HARE. 1994. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion [see comments]. Arthritis Rheum. 37(8): 1132-1137.
148. 148. JORGENSEN, C., N. BRESSOT, C. BOLOGNA & J. SANY. 1995. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J. Rheumatol. 22(10): 1829-1833.
149. 149. SALDANHA, C., G. TOUGAS & E. GRACE. 1986. Evidence for anti-inflammatory effect of normal circulating plasma cortisol. Clin. Exp. Rheumatol. 4(4): 365-366.
150. 150. MASI, A. T., D. B. JOSIPOVIC & W. E. JEFFERSON. 1984. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): Gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin. Arthritis Rheum. 14(1): 1-23.
151. 151. STERNBERG, E. M., W. S. YOUNG III, R. BERNARDINI, A. E. CALOGERO, G. P. CHROUSOS, P. W. GOLD & R. L. WILDER. 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86(12): 4771-4775.
152. 152. WILDER, R. L. 1996. Hormones and autoimmunity: Animal models of arthritis. Baillières Clin. Rheumatol. 10(2): 259-271.